SCHEMBL3440796

SCHEMBL3440796

Cc1ccccc1NCc1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 3/20 0.72
HTT P42858 4/20 0.61
MAPT P10636 3/20 0.61
HSD17B10 Q99714 2/20 0.59
HPGD P15428 3/20 0.56
KDM4E B2RXH2 3/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
ALDH1A1 P00352 1/20 0.55
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
CRHBP P24387 1/20 0.54
CYP2C19 P33261 1/20 0.54
CRHR2 Q13324 1/20 0.54
TSHR P16473 1/20 0.53
HDAC1 Q13547 1/20 0.53
HDAC8 Q9BY41 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL30496129 0.98 ADRA2C (0.70) ADRA2CHTTMAPTHSD17B10HPGD
Propionic Acid SCHEMBL28643153 0.88 ADRA2C (0.58) ADRA2CHTTMAPTHSD17B10HPGD
SCHEMBL2232108 0.86 HSD17B10 (0.60) ADRA2CHTTMAPTHSD17B10HPGD
SCHEMBL10669853 0.84 ADRA2C (0.64) ADRA2CHTTMAPTHPGDKDM4E
Iodide SCHEMBL29049215 0.84 HSD17B10 (0.58) ADRA2CHTTMAPTHSD17B10HPGD
Water SCHEMBL29049225 0.84 HSD17B10 (0.58) ADRA2CHTTMAPTHSD17B10HPGD
Hydrochloric Acid SCHEMBL4373569 0.84 HSD17B10 (0.58) ADRA2CHTTMAPTHSD17B10HPGD
Ammonia Solution, Strong SCHEMBL28850909 0.84 HSD17B10 (0.58) ADRA2CHTTMAPTHSD17B10HPGD
Bromide SCHEMBL29049211 0.84 HSD17B10 (0.58) ADRA2CHTTMAPTHSD17B10HPGD
SCHEMBL4571036 0.84 HSD17B10 (0.71) ADRA2CHTTMAPTHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2859069-B1 METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT FERRARA MARCELLO (IT) 2020-10-14 EP claimed
US-9328300-B2 Method, apparatus and chemical products for treating petroleum equipment FERRARA MARCELLO (IT) 2016-05-03 US claimed
EP-2859069-A1 METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT Ferrara, Marcello (IT) 2015-04-15 EP claimed
WO-2013156228-A1 METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT FERRARA MARCELLO (IT) 2013-10-24 WO claimed
US-20130270157-A1 METHOD, APPARATUS AND CHEMICAL PRODUCTS FOR TREATING PETROLEUM EQUIPMENT FERRARA MARCELLO (IT) 2013-10-17 US claimed
WO-1995020637-A2 HYDROCARBON OIL-AQUEOUS FUEL AND ADDITIVE COMPOSITIONS MEG S.N.C. DI SCOPELLITI SOFIA & C. (IT) 1995-08-03 WO claimed
EP-0166321-B1 HYDROPHOBIC POLYAMIDES BAYER AG (DE) 1990-08-08 EP claimed
EP-4694606-A1 RADIO WAVE SHIELDING BODY AND ADHESIVE COMPOSITION Zeon Corporation (JP) 2026-02-11 EP disclosed
CN-116102430-B Alkylation synthesis method for in-situ catalytic alcohols 中山大学 2025-03-14 CN disclosed
WO-2024204796-A1 RADIO WAVE SHIELDING BODY AND ADHESIVE COMPOSITION 日本ゼオン株式会社 2024-10-03 WO disclosed
US-11753363-B2 13-oxidized ingenol derivative and use thereof TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORP., LTD. TRADITIONAL CHINESE MEDICINE RESEARCH INSTITUTE (CN) 2023-09-12 US disclosed
US-11753363-B2 13-oxidized ingenol derivative and use thereof TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORP., LTD. TRADITIONAL CHINESE MEDICINE RESEARCH INSTITUTE (CN) 2023-09-12 US disclosed
WO-2023135533-A1 COMPOUNDS USEFUL IN THE PREVENTION AND/OR TREATMENT OF SENESCENT CELL-RELATED PATHOLOGIES AND DISEASES ISTITUTI CLINICI SCIENTIFICI MAUGERI SPA SB (IT) 2023-07-20 WO disclosed
US-4196212-A DIURETIC, ANTITHROMBOGENIC, SMOOTH MUSCLE RELAXANT, ANTIINFLAMMATORY MEAD JOHNSON & COMPANY (US) 1980-04-01 US disclosed
US-4196287-A Process for the catalytic production of 2-substituted pyridines LONZA LTD. (CH) 1980-04-01 US disclosed
US-4139530-A CATIONIC DYES BAYER AKTIENGESELLSCHAFT (DE) 1979-02-13 US disclosed
US-4115413-A ACID FREE BAYER AKTIENGESELLSCHAFT (DE) 1978-09-19 US disclosed
US-4072675-A DIURETICS, ANTICOAGULANTS, INOTROPIC AGENTS, ANTIINFLAMMATORY AGENTS, ANTIARRHYTHMIA AGENTS MEAD JOHNSON & COMPANY (US) 1978-02-07 US disclosed
US-4049714-A DIURETIC, ANTITHROMBOGENIC, ANTIARRYTHMIC, ANTIINFLAMMATORY, MUSCLE RELAXANTS MEAD JOHNSON & COMPANY (US) 1977-09-20 US disclosed
US-4041024-A FOR POLYAMIDES AND POLYURETHANES BAYER AKTIENGESELLSCHAFT (DT) 1977-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11753363-B2 13-oxidized ingenol derivative and use thereof MMP8, CXCL8, PMAIP1 ADRA2C 2767/4885HTT 4616/4885MAPT 4800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.